251 related articles for article (PubMed ID: 2421716)
1. Putative Ca2+ channels in cardiac membranes. Subcellular distribution of [3H]nitrendipine receptors.
Haase H; Vetter R; Will H; Will-Shahab L
Biomed Biochim Acta; 1986; 45(1-2):S223-6. PubMed ID: 2421716
[TBL] [Abstract][Full Text] [Related]
2. Developmental changes of Ca++ transport systems in chick heart.
Vetter R; Will H; Küttner I; Kemsies C; Will-Shahab L
Biomed Biochim Acta; 1986; 45(1-2):S219-22. PubMed ID: 3008712
[TBL] [Abstract][Full Text] [Related]
3. Modification of cardiac sarcolemmal Na+-Ca2+ exchange by diltiazem and verapamil.
Takeo S; Elimban V; Dhalla NS
Can J Cardiol; 1985 Mar; 1(2):131-8. PubMed ID: 2996725
[TBL] [Abstract][Full Text] [Related]
4. Binding of the calcium channel blocker nitrendipine to its receptor in purified sarcolemma from canine cardiac ventricle.
Sarmiento JG; Janis RA; Colvin RA; Triggle DJ; Katz AM
J Mol Cell Cardiol; 1983 Feb; 15(2):135-7. PubMed ID: 6304327
[TBL] [Abstract][Full Text] [Related]
5. Direct photoaffinity labeling of the high affinity nitrendipine-binding site in subcellular membrane fractions isolated from canine myocardium.
Campbell KP; Lipshutz GM; Denney GH
J Biol Chem; 1984 May; 259(9):5384-7. PubMed ID: 6325434
[TBL] [Abstract][Full Text] [Related]
6. [3H]nitrendipine receptors as markers of a class of putative voltage-sensitive Ca2+ channels in normal human skeletal muscle and in muscle from Duchenne muscular dystrophy patients.
Desnuelle C; Renaud JF; Delpont E; Serratrice G; Lazdunski M
Muscle Nerve; 1986 Feb; 9(2):148-51. PubMed ID: 2419753
[TBL] [Abstract][Full Text] [Related]
7. Sarcolemmal Na+-Ca2+ exchange and sarcoplasmic reticulum Ca2+ uptake in several cardiac preparations.
Vetter R; Kemsies C; Schulze W
Biomed Biochim Acta; 1987; 46(8-9):S375-81. PubMed ID: 2449183
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of purified bovine cardiac sarcolemma and potassium-stimulated calcium uptake.
Flockerzi V; Mewes R; Ruth P; Hofmann F
Eur J Biochem; 1983 Sep; 135(1):131-42. PubMed ID: 6309517
[TBL] [Abstract][Full Text] [Related]
9. Sarcolemmal Ca2+ transport activities in cardiac hypertrophy caused by pressure overload.
Nakanishi H; Makino N; Hata T; Matsui H; Yano K; Yanaga T
Am J Physiol; 1989 Aug; 257(2 Pt 2):H349-56. PubMed ID: 2548404
[TBL] [Abstract][Full Text] [Related]
10. Characterization of calcium antagonist receptors in highly purified porcine cardiac sarcolemma.
Haase H; Wallukat G; Vetter R; Will H
Biomed Biochim Acta; 1987; 46(8-9):S363-9. PubMed ID: 2829862
[TBL] [Abstract][Full Text] [Related]
11. Myocellular calcium regulation by the sarcolemmal membrane in the adult and immature rabbit heart.
Boucek RJ; Shelton ME; Artman M; Landon E
Basic Res Cardiol; 1985; 80(3):316-25. PubMed ID: 2411254
[TBL] [Abstract][Full Text] [Related]
12. Novel interactions of cations with dihydropyridine calcium antagonist binding sites in brain.
Bolger GT; Skolnick P
Br J Pharmacol; 1986 Aug; 88(4):857-66. PubMed ID: 3017494
[TBL] [Abstract][Full Text] [Related]
13. Binding of [3H]-nitrendipine and [3H]-diltiazem to rat myocardial sarcolemma.
Miwa N; Kanaide H; Nishimura J; Nakamura M
Arzneimittelforschung; 1986 Jul; 36(7):1059-62. PubMed ID: 3021180
[TBL] [Abstract][Full Text] [Related]
14. Influence of Mg++ on the effect of diltiazem to increase dihydropyridine binding to receptors on Ca++-channels in chick cardiac and skeletal muscle membranes.
Maan AC; Ptasienski J; Hosey MM
J Pharmacol Exp Ther; 1986 Dec; 239(3):768-74. PubMed ID: 2432217
[TBL] [Abstract][Full Text] [Related]
15. Dihydropyridine and peripheral type benzodiazepine binding sites: subcellular distribution and molecular size determination.
Doble A; Benavides J; Ferris O; Bertrand P; Menager J; Vaucher N; Burgevin MC; Uzan A; Gueremy C; Le Fur G
Eur J Pharmacol; 1985 Dec; 119(3):153-67. PubMed ID: 2419140
[TBL] [Abstract][Full Text] [Related]
16. Local anesthetics differentiate dihydropyridine calcium antagonist binding sites in rat brain and cardiac membranes.
Bolger GT; Marcus KA; Daly JW; Skolnick P
J Pharmacol Exp Ther; 1987 Mar; 240(3):922-30. PubMed ID: 3031279
[TBL] [Abstract][Full Text] [Related]
17. Lack of nitric oxide synthase depresses ion transporting enzyme function in cardiac muscle.
Zhou L; Burnett AL; Huang PL; Becker LC; Kuppusamy P; Kass DA; Kevin Donahue J; Proud D; Sham JS; Dawson TM; Xu KY
Biochem Biophys Res Commun; 2002 Jun; 294(5):1030-5. PubMed ID: 12074580
[TBL] [Abstract][Full Text] [Related]
18. Influence of long-term treatment of imidapril on mortality, cardiac function, and gene expression in congestive heart failure due to myocardial infarction.
Ren B; Shao Q; Ganguly PK; Tappia PS; Takeda N; Dhalla NS
Can J Physiol Pharmacol; 2004 Dec; 82(12):1118-27. PubMed ID: 15644955
[TBL] [Abstract][Full Text] [Related]
19. Physiological and pharmacological correlates of calcium antagonist receptors.
Wagner JA; Reynolds IJ; Snyder SH
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S1-9. PubMed ID: 2455102
[TBL] [Abstract][Full Text] [Related]
20. Characterization of verapamil binding sites in cardiac membrane vesicles.
Garcia ML; Trumble MJ; Reuben JP; Kaczorowski GJ
J Biol Chem; 1984 Dec; 259(24):15013-6. PubMed ID: 6096353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
